All data are based on the daily closing price as of August 1, 2025
h

HK inno.N

195940.KQ
31.87 USD
-0.43
-1.33%

Overview

Last close
31.87 usd
Market cap
902.78M usd
52 week high
38.09 usd
52 week low
21.69 usd
Target price
44.16 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.5116
Price/Book Value
1.0131
Enterprise Value
1.16B usd
EV/Revenue
1.7521
EV/EBITDA
17.2755

Key financials

Revenue TTM
597.24M usd
Gross Profit TTM
247.66M usd
EBITDA TTM
67.85M usd
Earnings per Share
N/A usd
Dividend
0.25 usd
Total assets
1.31B usd
Net debt
N/A usd

About

HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and hemodialysis; diabetes; hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, and hypertension with dyslipidemia; GERD, EE, NERD, GU and H.Pylori; pleural mesothelioma, non-small cell lung cancer, and mesothelioma, and colorectal cancer; and nutrition and intravenous nutrition. It also provides health and beverage products, such as hangover relief, ready to drink, health supplements and health functional foods, as well as active pharmaceutical ingredients. In addition, the company offers beauty products under the bewants, ScalpMed, and KLEDERMA RX brands. It also exports its products to Japan, Southeast Asia, Latin America, Europe, and the Middle East countries. HK inno.N Corporation was founded in 1984 and is headquartered in Cheongju-si, South Korea.
  • Symbol
    195940.KQ
  • Exchange
    KQ
  • Isin
    N/A
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Dal-Won Kwak
  • Headquarter
    Cheongju-si
  • Web site
    https://www.inno-n.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top